Parkman-Healthcare-Partners

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "KNSA",
  "NUVL",
  "EWTX",
  "INSM",
  "NAMS",
  "ORIC",
  null,
  "AORT",
  "PTCT",
  "ALNY",
  "VCYT",
  "ANIP",
  "FOLD",
  "QDEL",
  "BSX",
  "DVAX",
  "RXST",
  "LIVN",
  "PGEN",
  "ANNX",
  "RCUS",
  "SLN",
  "RLAY",
  "TVTX",
  "TERN",
  "NRIX",
  "MLYS",
  "REPL",
  "SNDX",
  "KROS",
  "GILD",
  "APGE",
  "GH",
  "CVRX",
  "NBIX",
  "KALV",
  "MNKD",
  "PHLT",
  null,
  "LUNG",
  "RPID",
  "SIBN",
  "TMCI",
  "EDAP",
  "PODD",
  "DOCS",
  "UNH",
  "DGX",
  "SYK",
  "UTHR",
  "UPB",
  "MBX",
  "SDGR",
  "ATEC",
  "ACLX",
  "QURE",
  "ARDX",
  "MRVI",
  "RMD",
  "EW",
  "THC",
  "ENTX",
  "ICAD",
  null,
  "IRWD",
  "URGN",
  "VRNA",
  "VRDN",
  "VYNE",
  "XERS",
  "XENE",
  "OPRX",
  "VERA",
  "RARE",
  "RVTY",
  "ZBH",
  "MCK",
  "PCVX",
  "AXGN",
  "BDX",
  "BCRX",
  "BMRN",
  "CSTL",
  "COO",
  "CRNX",
  "CVS",
  "DHR",
  "DAWN",
  "DXCM",
  "LLY"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 91
Total Value: 843125283
Accession Number: 0001420506-25-001258
Form Type: 13F-HR
CIK: parkman-healthcare-partners
Manager Name: Parkman-Healthcare-Partners

Data Enrichment

97% identified

88 identified3 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

91 positions • $843.1M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 5

Sort by:

REVVITY, INC.

RVTY|714046109

Shares:139.6K

Value:$14.8M

% of Portfolio:1.8% ($14.8M/$843.1M)

Edwards Lifesciences Corp

EW|28176E108

Shares:200.8K

Value:$14.6M

% of Portfolio:1.7% ($14.6M/$843.1M)

N72482206

Shares:359.6K

Value:$14.4M

% of Portfolio:1.7% ($14.4M/$843.1M)

Viridian Therapeutics, Inc.\DE

VRDN|92790C104

Shares:1.1M

Value:$14.3M

% of Portfolio:1.7% ($14.3M/$843.1M)

PTC THERAPEUTICS, INC.

PTCT|69366J200

Shares:280.3K

Value:$14.3M

% of Portfolio:1.7% ($14.3M/$843.1M)

DANAHER CORP /DE/

DHR|235851102

Shares:63.3K

Value:$13.0M

% of Portfolio:1.5% ($13.0M/$843.1M)

MANNKIND CORP

MNKD|56400P706

Shares:2.5M

Value:$12.5M

% of Portfolio:1.5% ($12.5M/$843.1M)

Ultragenyx Pharmaceutical Inc.

RARE|90400D108

Shares:304.2K

Value:$11.0M

% of Portfolio:1.3% ($11.0M/$843.1M)

QUEST DIAGNOSTICS INC

DGX|74834L100

Shares:62.6K

Value:$10.6M

% of Portfolio:1.3% ($10.6M/$843.1M)

Axogen, Inc.

AXGN|05463X106

Shares:536.8K

Value:$9.9M

% of Portfolio:1.2% ($9.9M/$843.1M)

Xeris Biopharma Holdings, Inc.

XERS|98422E103

Shares:1.8M

Value:$9.8M

% of Portfolio:1.2% ($9.8M/$843.1M)

Arcus Biosciences, Inc.

RCUS|03969F109

Shares:1.2M

Value:$9.5M

% of Portfolio:1.1% ($9.5M/$843.1M)

Schrodinger, Inc.

SDGR|80810D103

Shares:481.5K

Value:$9.5M

% of Portfolio:1.1% ($9.5M/$843.1M)

Edgewise Therapeutics, Inc.

EWTX|28036F105

Shares:425.4K

Value:$9.4M

% of Portfolio:1.1% ($9.4M/$843.1M)

Replimune Group, Inc.

REPL|76029N106

Shares:950.4K

Value:$9.3M

% of Portfolio:1.1% ($9.3M/$843.1M)

DEXCOM INC

DXCM|252131107

Shares:130.4K

Value:$8.9M

% of Portfolio:1.1% ($8.9M/$843.1M)

KalVista Pharmaceuticals, Inc.

KALV|483497103

Shares:753.8K

Value:$8.7M

% of Portfolio:1.0% ($8.7M/$843.1M)

Day One Biopharmaceuticals, Inc.

DAWN|23954D109

Shares:1.0M

Value:$8.3M

% of Portfolio:1.0% ($8.3M/$843.1M)

Nuvalent, Inc.

NUVL|670703107

Shares:110.0K

Value:$7.8M

% of Portfolio:0.9% ($7.8M/$843.1M)

BIOCRYST PHARMACEUTICALS INC

BCRX|09058V103

Shares:1.0M

Value:$7.5M

% of Portfolio:0.9% ($7.5M/$843.1M)

Instrument	Shares		Other Manager	Value	% of Portfolio
REVVITY, INC.(RVTYcusip714046109)	139.6K	QoQ NEW(+139.6K) YoY NEW(+139.6K)	All Managers (Combined)	$14.8M	1.8% ($14.8M/$843.1M)	QoQ NEW(+$14.8M) YoY NEW(+$14.8M)
Edwards Lifesciences Corp(EWcusip28176E108)	200.8K	QoQ +38.29% (+55.6K) YoY NEW(+200.8K)	All Managers (Combined)	$14.6M	1.7% ($14.6M/$843.1M)	QoQ +35.39% (+$3.8M) YoY NEW(+$14.6M)
(cusipN72482206)✕	359.6K	QoQ NEW(+359.6K) YoY NEW(+359.6K)	All Managers (Combined)	$14.4M	1.7% ($14.4M/$843.1M)	QoQ NEW(+$14.4M) YoY NEW(+$14.4M)
Viridian Therapeutics, Inc.\DE(VRDNcusip92790C104)	1.1M	QoQ -2.12% (-23.1K) YoY NEW(+1.1M)	All Managers (Combined)	$14.3M	1.7% ($14.3M/$843.1M)	QoQ -31.17% (-$6.5M) YoY NEW(+$14.3M)
PTC THERAPEUTICS, INC.(PTCTcusip69366J200)	280.3K	QoQ +58.04% (+102.9K) YoY NEW(+280.3K)	All Managers (Combined)	$14.3M	1.7% ($14.3M/$843.1M)	QoQ +78.41% (+$6.3M) YoY NEW(+$14.3M)
DANAHER CORP /DE/(DHRcusip235851102)	63.3K	QoQ NEW(+63.3K) YoY NEW(+63.3K)	All Managers (Combined)	$13.0M	1.5% ($13.0M/$843.1M)	QoQ NEW(+$13.0M) YoY NEW(+$13.0M)
MANNKIND CORP(MNKDcusip56400P706)	2.5M	QoQ -20.24% (-632.9K) YoY +3.65% (+87.9K)	All Managers (Combined)	$12.5M	1.5% ($12.5M/$843.1M)	QoQ -37.60% (-$7.6M) YoY +15.09% (+$1.6M)
Ultragenyx Pharmaceutical Inc.(RAREcusip90400D108)	304.2K	QoQ +203.76% (+204.1K) YoY NEW(+304.2K)	All Managers (Combined)	$11.0M	1.3% ($11.0M/$843.1M)	QoQ +161.44% (+$6.8M) YoY NEW(+$11.0M)
QUEST DIAGNOSTICS INC(DGXcusip74834L100)	62.6K	QoQ -30.72% (-27.8K) YoY NEW(+62.6K)	All Managers (Combined)	$10.6M	1.3% ($10.6M/$843.1M)	QoQ -22.30% (-$3.0M) YoY NEW(+$10.6M)
Axogen, Inc.(AXGNcusip05463X106)	536.8K	QoQ +46.79% (+171.1K) YoY NEW(+536.8K)	All Managers (Combined)	$9.9M	1.2% ($9.9M/$843.1M)	QoQ +64.78% (+$3.9M) YoY NEW(+$9.9M)
Xeris Biopharma Holdings, Inc.(XERScusip98422E103)	1.8M	QoQ +207.76% (+1.2M) YoY +1668.49% (+1.7M)	All Managers (Combined)	$9.8M	1.2% ($9.8M/$843.1M)	QoQ +398.41% (+$7.8M) YoY +4293.23% (+$9.6M)
Arcus Biosciences, Inc.(RCUScusip03969F109)	1.2M	QoQ -4.56% (-58.2K) YoY +367.69% (+955.7K)	All Managers (Combined)	$9.5M	1.1% ($9.5M/$843.1M)	QoQ -49.68% (-$9.4M) YoY +94.45% (+$4.6M)
Schrodinger, Inc.(SDGRcusip80810D103)	481.5K	QoQ -14.49% (-81.6K) YoY -51.85% (-518.5K)	All Managers (Combined)	$9.5M	1.1% ($9.5M/$843.1M)	QoQ -12.50% (-$1.4M) YoY -64.79% (-$17.5M)
Edgewise Therapeutics, Inc.(EWTXcusip28036F105)	425.4K	QoQ +11.60% (-44.2K) YoY -34.91% (-228.2K)	All Managers (Combined)	$9.4M	1.1% ($9.4M/$843.1M)	QoQ -8.04% (-$818.4K) YoY -21.50% (-$2.6M)
Replimune Group, Inc.(REPLcusip76029N106)	950.4K	QoQ +9.27% (-80.6K) YoY NEW(+950.4K)	All Managers (Combined)	$9.3M	1.1% ($9.3M/$843.1M)	QoQ -12.02% (-$1.3M) YoY NEW(+$9.3M)
DEXCOM INC(DXCMcusip252131107)	130.4K	QoQ +65.96% (+51.8K) YoY -24.05% (-41.3K)	All Managers (Combined)	$8.9M	1.1% ($8.9M/$843.1M)	QoQ +45.73% (+$2.8M) YoY -62.60% (-$14.9M)
KalVista Pharmaceuticals, Inc.(KALVcusip483497103)	753.8K	QoQ NEW(+753.8K) YoY NEW(+753.8K)	All Managers (Combined)	$8.7M	1.0% ($8.7M/$843.1M)	QoQ NEW(+$8.7M) YoY NEW(+$8.7M)
Day One Biopharmaceuticals, Inc.(DAWNcusip23954D109)	1.0M	QoQ +4.26% (-42.7K) YoY +50.78% (-351.4K)	All Managers (Combined)	$8.3M	1.0% ($8.3M/$843.1M)	QoQ -34.74% (-$4.4M) YoY -27.61% (-$3.2M)
Nuvalent, Inc.(NUVLcusip670703107)	110.0K	QoQ +366.28% (+86.4K) YoY +130.06% (+62.2K)	All Managers (Combined)	$7.8M	0.9% ($7.8M/$843.1M)	QoQ +322.44% (+$6.0M) YoY +117.28% (+$4.2M)
BIOCRYST PHARMACEUTICALS INC(BCRXcusip09058V103)	1.0M	QoQ +361.34% (+783.7K) YoY NEW(+1.0M)	All Managers (Combined)	$7.5M	0.9% ($7.5M/$843.1M)	QoQ +360.11% (+$5.9M) YoY NEW(+$7.5M)